Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

NCT01171729 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Cancer

Interventions

BIOLOGICAL: Autologous dendritic cell

Sponsor

Samsung Medical Center

Collaborators

[object Object]